A non-steroidal antiandrogen (NSAA) used to treat prostate cancer is nilutamide, also known as nilandron. Male hormones called androgens, which this medication blocks, can slow the growth and metastasis of prostate cancer cells. Users of Welzo can use this article for informational purposes to better understand Nilandron.

Health Benefits

Nilandron may have several health advantages, such as:

Reducing the likelihood that prostate cancer will spread

Improving the quality of life

Increasing the survival rate

Side Effects and Risks

Several negative effects of nilandrolone include:

Heat waves

A decline in sex desire

Tenderness or enlargement of the breasts

• exhaustion

- aversion

Nilandron may also raise your risk of contracting additional illnesses, including:

The cataracts

A. Osteoporosis

Liver injury

Tablets of the prescription drug nilandron are readily available. Typically, it is taken once per day, with or without food.

It is crucial to discuss the potential risks and advantages of taking Nilandron with your healthcare professional before beginning treatment.


Nilandron is typically started at 150 mg once daily. To achieve the desired effect, your healthcare provider may change your dose as necessary.

Usually taken for two to four years, nilandron is used to treat prostate cancer.


If you take any other medications, vitamins, or herbs, nilandrolone may interact with them. When a substance modifies how a drug functions, there is an interaction. This could be harmful or stop the medication from working properly.

Your healthcare provider should carefully manage all of your medications to help prevent interactions. Tell your doctor about all of the drugs, vitamins, and herbal remedies you are taking. Consult your doctor or pharmacist to learn how this medication may interact with other medications you are taking.

Mechanism of Action

Nilandron functions by obstructing androgen's effects. Androgens are male hormones that can encourage prostate cancer cells to multiply and spread. Nilandron can slow the development and metastasis of prostate cancer cells by preventing the effects of androgens.


Following oral administration, nilandrol is completely and quickly absorbed. Within 2 to 4 hours (h) of a dose, nilandron reaches its highest blood concentration (Cmax).

Nilandron has a volume of distribution (Vd) of about 140 liters and is widely distributed throughout the body.

Nilandron is primarily excreted from the body by the kidneys. Nilandron has a mean elimination half-life (t1/2) of about 12 days.